These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1119 related items for PubMed ID: 11089434

  • 1. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 2. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T, Hotta T.
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB, Eisenhauer E, Wainman N, Corbett WE, Zaentz SD, Daeninck PJ.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [Abstract] [Full Text] [Related]

  • 4. The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission.
    Zák P, Chrobák L, Dedic K.
    Neoplasma; 2001 Apr; 48(1):72-5. PubMed ID: 11327542
    [Abstract] [Full Text] [Related]

  • 5. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M, Rolović Z, Vuković S, Elezović I, Tomić D.
    Srp Arh Celok Lek; 1990 Apr; 118(7-8):277-84. PubMed ID: 2097776
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Apr; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS, Moore D, Cassileth PA, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O'Connell MJ.
    N Engl J Med; 1987 Apr 02; 316(14):825-30. PubMed ID: 2434850
    [Abstract] [Full Text] [Related]

  • 10. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Apr 02; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
    Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D.
    Br J Haematol; 2009 Jun 02; 145(6):733-40. PubMed ID: 19344416
    [Abstract] [Full Text] [Related]

  • 12. Hairy cell leukemia. Current management.
    Doane LL, Ratain MJ, Golomb HM.
    Hematol Oncol Clin North Am; 1990 Apr 02; 4(2):489-502. PubMed ID: 2182604
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W, Weltermann A, Chott A, Gisslinger H, Valent P, Jäger U, Geissler K, Lechner K.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1027-30. PubMed ID: 10677889
    [Abstract] [Full Text] [Related]

  • 14. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL, Lauria F, Salvucci M, Rondelli D, Raspadori D, Bendandi M, Magagnoli M, Tura S.
    Haematologica; 1997 Dec 23; 82(2):152-5. PubMed ID: 9175317
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
    Shimoyama M, Tobinai K, Yamaguchi K, Hirashima K, Itoh S, Konishi H, Mikuni C, Togawa A, Hotta T, Toyoda N.
    Jpn J Clin Oncol; 1992 Dec 23; 22(6):406-10. PubMed ID: 1291757
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
    Lauria F, Lenoci M, Annino L, Raspadori D, Marotta G, Bocchia M, Forconi F, Gentili S, La Manda M, Marconcini S, Tozzi M, Baldini L, Zinzani PL, Foà R.
    Haematologica; 2001 Oct 23; 86(10):1046-50. PubMed ID: 11602410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group].
    Raemaekers JM, van 't Veer MB, Bogman MJ.
    Ned Tijdschr Geneeskd; 1996 Aug 03; 140(31):1600-4. PubMed ID: 8768814
    [Abstract] [Full Text] [Related]

  • 20. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug 03; 15(84):143-4. PubMed ID: 16989031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.